ATTO- Attovia Therapeutics, Inc.

Trade Summary

1 month ago, Sanofi, serving as 10% owner Owner at Attovia Therapeutics, Inc. (ATTO), purchased 300,000 shares at $17.00 per share, for a total transaction value of $5,100,000.00. Following this transaction, Sanofi now holds 1,082,855 shares of ATTO.

This purchase represents a 38.32% increase in Sanofi's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 3:45 PM ET, 1 day after the trade was made.

Attovia Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.